Literature DB >> 15076268

Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression.

Yousha Mirza1, Jennifer Tang, Aileen Russell, S Preeya Banerjee, Rashmi Bhandari, Jennifer Ivey, Michelle Rose, Gregory J Moore, David R Rosenberg.   

Abstract

OBJECTIVE: To examine in vivo glutamatergic neurochemical alterations in the anterior cingulate cortex of children with major depressive disorder (MDD).
METHOD: Single-voxel proton magnetic resonance spectroscopic (H-MRS) examinations of the anterior cingulate cortex were conducted in 13 psychotropic-naïve children and adolescents with MDD and 13 age- and sex-matched healthy children and adolescents. Ten of the 13 MDD patient-control pairs also had a H-MRS examination of occipital cortex.
RESULTS: Anterior cingulate glutamatergic (Glx) concentrations were significantly lower (19% decrease) in MDD patients versus controls (9.27 +/- 0.43 versus 11.47 +/- 0.26, respectively, p = 0.000). Reduced anterior cingulate Glx in MDD patients was associated with increased severity of functional impairment. These results remained comparably significant after controlling for age and anterior cingulate volume. Occipital cortex Glx did not differ between MDD patients and controls.
CONCLUSIONS: These preliminary findings provide new evidence of localized functional neurochemical marker alterations in Glx in anterior cingulate cortex in pediatric MDD. Altered anterior cingulate Glx neurotransmission may be involved in the pathogenesis of MDD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15076268     DOI: 10.1097/00004583-200403000-00017

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  34 in total

1.  Altered error-related brain activity in youth with major depression.

Authors:  Cecile D Ladouceur; John S Slifka; Ronald E Dahl; Boris Birmaher; David A Axelson; Neal D Ryan
Journal:  Dev Cogn Neurosci       Date:  2012-02-08       Impact factor: 6.464

2.  Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.

Authors:  José Javier Miguel-Hidalgo; Robert Waltzer; Angela A Whittom; Mark C Austin; Grazyna Rajkowska; Craig A Stockmeier
Journal:  J Affect Disord       Date:  2010-06-26       Impact factor: 4.839

3.  Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder.

Authors:  Paul Daniel Arnold; Frank P Macmaster; Gregory L Hanna; Margaret A Richter; Tricia Sicard; Eliza Burroughs; Yousha Mirza; Phillip C Easter; Michelle Rose; James L Kennedy; David R Rosenberg
Journal:  Brain Imaging Behav       Date:  2009-03-01       Impact factor: 3.978

4.  Co-localization of corticotropin-releasing factor and vesicular glutamate transporters within axon terminals of the rat dorsal raphe nucleus.

Authors:  Maria Waselus; Elisabeth J Van Bockstaele
Journal:  Brain Res       Date:  2007-08-14       Impact factor: 3.252

Review 5.  A brief history of the development of antidepressant drugs: from monoamines to glutamate.

Authors:  Todd M Hillhouse; Joseph H Porter
Journal:  Exp Clin Psychopharmacol       Date:  2015-02       Impact factor: 3.157

Review 6.  Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Authors:  Gerard Sanacora; Giulia Treccani; Maurizio Popoli
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

Review 7.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

8.  Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression.

Authors:  Anteneh M Feyissa; Agata Chandran; Craig A Stockmeier; Beata Karolewicz
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-10-25       Impact factor: 5.067

Review 9.  The As and Ds of stress: metabolic, morphological and behavioral consequences.

Authors:  Lawrence P Reagan; Claudia A Grillo; Gerado G Piroli
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

10.  Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.

Authors:  Rebecca B Price; Dikoma C Shungu; Xiangling Mao; Paul Nestadt; Chris Kelly; Katherine A Collins; James W Murrough; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.